Free radicals, antioxidants, and human disease: Where are we now?

The Journal of Laboratory and Clinical Medicine

Volumn 119, Issue 6, 1992, Pages 598-620

  Halliwell, Barry ^a,b   Gutteridge, John M C ^a,b   Cross, Carroll E ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; CAROTENOID; CHELATING AGENT; DEFEROXAMINE; FREE RADICAL; GLUTATHIONE; HYDROGEN PEROXIDE; LACTOFERRIN; SUPEROXIDE; THIOL DERIVATIVE; TRANSFERRIN; TROLOX C;

ADULT RESPIRATORY DISTRESS SYNDROME; CELL DAMAGE; CELL METABOLISM; DNA FINGERPRINTING; DRUG BIOAVAILABILITY; DRUG MECHANISM; DRUG SAFETY; ELECTRON SPIN RESONANCE; ELECTRON TRANSPORT; ENZYME ACTIVATION; HUMAN; IMMUNOMODULATION; IRON CHELATION; LIPID PEROXIDATION; OXIDATION REDUCTION REACTION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; TISSUE INJURY;

ANTIOXIDANTS; DISEASE; DNA DAMAGE; FREE RADICALS; HUMAN; MODELS, BIOLOGICAL; SUPPORT, NON-U.S. GOV'T;

EID: 0026636441     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (280)

1. Reactive Oxygen Species, Antioxidants, and Acquired Immunodeficiency Syndrome
2. Pharmacologic approach to tissue injury mediated by free radicals and other reactive oxygen metabolites
3. Free radicals in medicine. II: involvement in human disease
4. Hypothesis: is lung disease after silicate inhalation caused by oxidant generation?
5. Oxygen radicals and lung injury
6. Lipid peroxidation, oxygen radicals, cell damage and antioxidant therapy
7. Superoxide dismutase: an adaptation to a paramagnetic gas
8. −
9. Evidence for superoxide radical-dependent coronary vasospasm after angioplasty in intact dogs
10. Peroxynitrite oxidation of sulfhydryls
11. Superoxide, iron, vascular endothelium and reperfusion injury
12. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitrix oxide and superoxide
13. Inhibition of coronary artery superoxide dismutase attenuates endothelium-dependent and -independent nitrovasodilator relation
14. Assays of metabolic superoxide production in Escherichia coli
15. Superoxide sensitivity of the Escherichia coli aconitase
16. The oxidative inactivation of mitochondrial electron transport chain components and ATPase
17. Chronic granulomatous disease
18. Modulation of fibroblast proliferation by oxygen free radicals
19. The B-lymphocyte: a newly-recognized source of reactive oxygen species with immunoregulatory potential
20. Human fibroblasts release reactive oxygen species in response to treatment with synovial fluids from patients suffering from arthritis
21. Oxygen radical production by transformed B lymphocytes
22. The molecular genetics of superoxide dismutase in E. coli
23. Genetic and biochemical characterization of Cu, Zn superoxide dismutase mutants in Saccharomyces cerrvisiae
24. Transgenic mice with expression of elevated levels of copper-zinc superoxide dismutase in the lungs are resistant to pulmonary oxygen toxicity
25. Effects of overproduction of superoxide dismutase on the toxicity of paraquat towards Escherichia coli
26. Superoxide dismutase rich bacteria
27. Expression of bovine superoxide dismutase in Drosophila melanogaster augments resistance to oxidative stress
28. Association of Antioxidant Systems in the Protection of Human Fibroblasts Against Oxygen Derived Free Radicals
29. Down syndrome clinical symptoms are manifested in transfected cells and transgenic mice overexpressing the human Cu/Zn-superoxide dismutase gene
30. Manganese superoxide dismutase can reduce cellular damage mediated by oxygen radicals in transgenic plants
31. Enhancement of erythrocyte superoxide dismutase activity: effects on cellular oxidant defense
32. Mechanism of hydrogen peroxide formation catalyzed by NADPH oxidase in thyroid plasma membrane
33. The control of oxidative stress at fertilization
34. Oxygen free radicals and iron in relation to biology and medicine
35. Hydrogen peroxide is involved in hamster sperm capacitation in vitro
36. In vivo generation of hydrogen peroxide in the rat corpus Interim during luteolysis
37. κB transcription factor and HIV-1
38. N-Acetylcysteine inhibits latent HIV expression in chronically infected cells
39. Activation of human immunodeficiency virus type 1 by oxidative stress
40. Mechanisms of oxidant-mediated cell injury
41. Oxidation of articular cartilage glyceraldehyde-3-phosphate dehydrogenase (G3PDH) occurs in vivo during carrageenin-induced arthritis
42. Light-activation of fructose bisphosphatase in isolated spinach chloroplasts and deactivation by hydrogen peroxide
43. Rapid inactivation of aconitase by hydrogen peroxide
44. DNA damage by oxygen-derived species
45. Role of free radicals and catalytic metal ions in human disease: an overview
46. Free radicals formed during the oxidation and reduction of peroxides
47. Electron spin resonance studies. Part XIV: hydroxylation. Part IV: reactions of anisole, acetanilide, fluorobenzene and some phenols with the titanium (III)-hydrogen peroxide system
48. On the participation of higher oxidation states of iron and copper in Fenton reactions
49. Copper ion-dependent damage to the bases in DNA in the presence of hydrogen peroxide
50. Copper-phenanthroline-induced site-specific oxygen radical damage to DNA
51. Copper loading of hearts increases post ischemic reperfusion injury
52. Studies of Hypervalent Iron
53. The nature of the primary oxidants in oxidations mediated by metal ions
54. The reaction of ferrous EDTA with hydrogen peroxide: evidence against hydroxyl radical formation
55. Role of metals in oxygen radical reactions
56. Free radical modification of prosthetic heme groups
57. Chemical models and radiation damage
58. Superoxide dismutase and Fenton chemistry
59. The deoxyribose method: a simple test-tube assay for determination of rate constants for reactions of hydroxyl radicals
60. Endocytosis of superoxide dismutase is required in order for the enzyme to protect hepatocytes from the cytotoxicity of hydrogen peroxide
61. Increases in cytosolic calcium ion concentration can be dissociated from the killing of cultured hepatocytes by tert-butyl hydroperoxide
62. DNA damage and oxygen radical toxicity
63. Oxidants and human disease: some new concepts
64. 2+ in toxic cell killing
65. Iron release and erythrocyte damage in allyl alcohol intoxication in mice
66. Inhibition of the iron-catalyzed formation of hydroxyl radicals from superoxide and of lipid peroxidation by desferrioxamine
67. Superoxide dismutase inhibits the superoxide-driven Fenton reaction at two different levels: implications for a wider protective role
68. Superoxide-Dependent Formation of Hydroxyl Radicals from Ferric-Complexes and Hydrogen Peroxide: An Evaluation of Fourteen Iron Chelators
69. Damage to the bases in DNA induced by hydrogen peroxide and ferric ion chelates
70. DNA damage and free radicals
71. A mechanism for the production of ethylene from methional
72. Superoxide-dependent production of hydroxyl radical catalyzed by iron—EDTA complex
73. Evidence for superoxide-dependent reduction of iron(III) and its role in enzymegenerated hydroxyl radical formation
74. Superoxide-dependent formation of hydroxyl radicals in the presence of iron chelates
75. Iron transport and storage
76. Cellular iron metabolism in health and disease
77. The antioxidants of human extracellular fluids
78. Iron mobilization from ferritin by superoxide derived from stimulated polymorphonuclear leukocytes
79. The kinetics of the reaction of ferritin with superoxide
80. On the limited ability of superoxide to release iron from ferritin
81. Iron promoters of the Fenton reaction and lipid peroxidation can be released from haemoglobin by peroxides
82. Formation of hydroxyl radicals from hydrogen peroxide in the presence of iron
83. Formation of hydroxyl radicals in biological systems
84. Radical-promoting loosely bound iron in biological fluids and the bleomycin assay
85. Low-molecular-weight iron complexes and oxygen radical reactions in idiopathic hemochromatosis
86. Non-transferrin-bound iron in plasma or serum from patients with idiopathic hemochromatosis
87. Non-caeruloplasmin copper and ferroxidase activity in mammalian serum
88. Continuous monitoring of in vitro oxidation of human low density lipoprotein
89. LIPID PEROXIDATION AND THE CYTOTOXICITY OF COPPER
90. Copper salt-dependent hydroxyl radical formation
91. The cupric ion catalysis of the cleavage of γ-globulin and other proteins by hydrogen peroxide
92. Unusual copper-induced sensitization of the biological damage due to superoxide radicals
93. Hydroperoxide metabolism in mammalian organs
94. Catalases and peroxidases and glutathione and hydrogen peroxide: Mysteries of the bestiary
95. Phospholipid hydroperoxide glutathione peroxidase is the 18KDa selenoprotein expressed in human tumor cell lines
96. The antioxidant activity of haptoglobin towards haemoglobin-stimulated lipid peroxidation
97. Vitamin E as an in vitro and in vivo antioxidant
98. Will antioxidant nutrients slow the aging process?
99. Biokinetics of dietary RRR-alpha-tocopherol in the male guinea pig at three dietary levels of vitamin C and two levels of vitamin E
100. Antioxidant effects of ubiquinones in microsomes and mitochondria are mediated by tocopherol recycling
101. The antioxidant role of vitamin C
102. Ascorbate is an outstanding antioxidant in human blood plasma
103. How to Characterize a Biological Antioxidant
104. Enzymatic recycling of oxidized ascorbate in pig heart: one-electron versus two-electron pathway
105. Some properties of the ascorbate free radical
106. The Determination of Dehydroascorbic Acid and Ascorbic acid in the Serum and Synovial Fluid of Patients with Rheumatoid Arthritis (RA)
107. Oxidative stress and abnormal cholesterol metabolism in patients with adult respiratory distress syndrome
108. Vitamin C and cancer prevention: the epidemiologic evidence.
109. Risk of angina pectoris and plasma concentrations of vitamins A, C and E and carotene
110. Drug antioxidant effects: a basis for drug selection?
111. Role of tocopherols in the protection of biological systems against oxidative damage
112. Sulfur-centered free radicals
113. Esr Investigations of the Reactions of Radiation-Produced Thiyl and DNA Peroxyl Radicals: Formation of Sulfoxyl Radicals
114. 1-antiproteinase by sulphur-containing radicals derived from penicillamine
115. Superoxide dismutase ten years later: a drug in search of a function
116. Therapeutic Usages of Oxygen Radical Scavengers in Human Diseases: Myths and Realities
117. Free radicals and their involvement during long-term myocardial ischemia and reperfusion
118. Inverse correlation between plasma vitamin E and mortality from ischemic heart disease in cross-cultural epidemiology.
119. Therapeutic potential of vitamin E in the pathogenesis of spontaneous atherosclerosis
120. The neonatal erythrocyte and its oxidative susceptibility
121. Vitamin E supplementation and periventricular hemorrhage in the newborn.
122. Vitamin E and neurological function
123. Neurochemical, neurophysiological and neuropathological studies in vitamin E deficiency
124. Enhancement of bleomyciniron free radical damage to DNA by antioxidants and their inhibition of lipid peroxidation
125. An Evaluation of the Antioxidant and Potential Pro-Oxidant Properties of Food Additives and the Trolox C., Vitamin E and Probucol
126. Antioxidant and pro-oxidant actions of the plant phenolics quercetin, gossypol and myricetin
127. Antioxidant activity of probucol and its analogues in hypercholesterolemic Watanabe rabbits
128. Concentration-dependent antioxidant activity of probucol in low density lipoprotein in vitro: probucol degradation precedes lipoprotein oxidation
129. Beyond cholesterol
130. Identification of a thioredoxin-related protein associated with plasma membranes
131. Mechanisms of carbon tetrachloride toxicity
132. Glutathione-depleting agents and lipid peroxidation
133. A survey of chemicals inducing lipid peroxidation in biological systems
134. Effects of oxidative stress caused by hyperoxia and diquat
135. Membrane proteins are critical targets in free radical mediated cytolysis
136. Mechanisms of oxidant injury of cells
137. Metal-catalyzed oxidation of proteins
138. Age influence on oxidative events during brain ischemia/reperfusion
139. Reperfusion of infarcted tissue and free radicals
140. A compilation of specific bimolecular rate constants for the reactions of hydrated electrons, hydrogen atoms and hydroxyl radicals with inorganic and organic compounds in aqueous solution
141. The iron-binding and hydroxyl radical scavenging action of anti-inflammatory drugs
142. Cytotoxicity from Coupled Redox Cycling of Autoxidizing Xenobiotics and Metals: A Selective Critical Review and Commentary on Work-in-Progress
143. Studies of the limited degradation of mucus glycoproteins
144. Site-specific modification of albumin by free radicals
145. The pharmacology of ebselen
146. Protection against tissue damage in vivo by desferrioxamine
147. Ocular toxicity of high-dose intravenous desferrioxamine
148. Cerebral and ocular toxicity induced by desferrioxamine
149. Vision and hearing during deferoxamine therapy
150. Iron-mediated radical reactions upon reperfusion contribute to myocardial “stunning”
151. Oxygen radicals: mediators of gastrointestinal pathophysiology
152. The role of metal ions in ischemia/reperfusion injury in skin flaps
153. Protection by desferrioxamine against histopathological changes in the liver in the post-oligemic phase of clinical hemorrhagic shock in dogs
154. Reactivity of hydroxyl and hydroxyl-like radical discriminated by release of thiobarbituric-acid-reactive material from deoxyribose, nucleosides and benzoate
155. Evidence that desferrioxamine cannot enter cells by passive diffusion
156. The development of iron chelating drugs
157. Oral iron chelators
158. The study of iron mobilization from transferrin using α-ketohydroxy heteroaromatic chelators
159. Iron mobilization from lactoferrin by chelators at physiological pH
160. Superoxide-dependent and ascorbate-dependent formation of hydroxyl radical from hydrogen peroxide in the presence of iron
161. Stimulated neutrophils limit iron-catalyzed hydroxyl radical formation as detected by spin-trapping
162. Inhibition of lipid peroxidation by the iron-binding protein lactoferrin
163. In vitro screening of iron chelators using models of free radical damage
164. A global view of human selenium nutrition
165. Molecular biology of selenium, with implications for its metabolism
166. Vitamin E and retinopathy of prematurity: still controversial
167. Tissue destruction by neutrophils
168. Oxidants, inflammation and the anti-inflammatory drugs
169. Free radicals and myocardial ischaemia and reperfusion injury
170. Bleomycin-detectable iron in serum from leukaemic patients before and after chemotherapy
171. oxorubicin-induced cardiac toxicity
172. Brain iron
173. Oxygen radicals and the nervous system
174. The inhibition of lipid autoxidation by human serum and its relationship to serum proteins and alpha tocopherol
175. Central nervous system trauma and stroke
176. Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson's disease
177. Transition metals, ferritin, glutathione and ascorbic acid in Parkinsonian brains
178. Selective increase of iron in substantia nigra zona compacta of Parkinsonian brains
179. Muscle cell leakage of myoglobin after long-term exercise and relation to the individual performances
180. The role of reperfusion-induced injury in the pathogenesis of the crush syndrome
181. Hemoglobin potentiates central nervous system damage
182. Hemoglobin potentiates oxidant injury in isolated rat lungs
183. Detection of ferryl myoglobin in the isolated ischemic rat heart
184. Free radicals mediate actions of oxyhemoglobin on cerebrovascular smooth muscle cells
185. The generation of ferryl or hydroxyl radicals during interaction of haemoproteins with hydrogen peroxide
186. Exposure of endothelial cells to free heme potentiates damage mediated by granulocytes and toxic oxygen species
187. Antioxidant protection by haemopexin of haem-stimulated lipid peroxidation
188. Hematin- and peroxide-catalyzed peroxidation of phospholipid liposomes
189. Initiation of lipid peroxidation in biological systems
190. Detection of myoglobin-derived radicals on reaction of metmyoglobin with hydrogen peroxide and other peroxidic compounds
191. The myoglobin-derived radical formed on reaction of metmyoglobin with hydrogen peroxide is not a tyrosine peroxyl radical
192. The suppression of iron release from activated myoglobin by physiological electron donors and by desferrioxamine
193. Inhibition of mammalian 5-lipoxygenase and cyclo-oxygenase by flavonoids and phenolic dietary additives
194. Oxidant activity in expired breath of patients with adult respiratory distress syndrome
195. Spontaneous chemiluminescence of human breath
196. Increased hydrogen peroxide in the expired breath of patients with acute hypoxemic respiratory failure
197. Radio-isotopic determination of subnanomolar amounts of peroxide
198. Spin trapping and associated vocabulary
199. Spin-trapping of superoxide by 5,5′-dimethyl-l-pyrroline N-oxide: application to isolated perfused organs
200. Marked reduction of free radical generation and contractile dysfunction by antioxidant therapy begun at the time of reperfusion: evidence that myocardial “stunning” is a form of reperfusion injury
201. Excretion, metabolism and tissue distribution of a spin trapping agent, alpha-phenyl-N-tert-butyl-nitrone (PBN) in rats
202. Scatchard analysis of methane sulfinic acid production from dimethyl sulfoxide
203. Methods for the measurement of hydroxyl radicals in biochemical systems
204. Aromatic hydroxylation of salicylate as a potential measure of hydroxyl radical formation in vivo
205. Hydroxylation of salicylate by microsomal fractions and cytochrome P-450
206. Use of salicylate with high pressure liquid chromatography as a sensitive measure of hydroxyl free radicals in adriamycin-treated rats
207. Hyperoxia and salicylate metabolism
208. High-performance liquid chromatographic detection of hydroxylated benzoic acids as an indirect measure of hydroxyl radical in heart: its possible links with myocardial reperfusion injury
209. Production of singlet oxygen-derived hydroxyl radical adducts during merocyanine-540—mediated photosensitization: analysis by ESR-spin trapping and HPLC with electrochemical detection
210. Aromatic hydroxylation of phenylalanine as an assay for hydroxyl radicals
211. Detecting irradiated foods: use of hydroxyl radical biomarkers
212. Hydroxylation of phenylalaine by the hypoxanthine-xanthine oxidase system
213. Demonstration of hydroxyl radical generation in “stunned” myocardium of intact dogs using aromatic hydroxylation of phenylalanine
214. Uric acid provides an antioxidant defense in humans against oxidant and radical-caused aging and cancer; a hypothesis
215. Human urate oxidase gene: cloning and partial sequence analysis reveal a stop codon within the fifth exon
216. Measurement of allantoin and uric acid in human body fluids
217. Action of biologically-relevant oxidizing species upon uric acid
218. Oxidative damage to plasma constituents by ozone
219. Comparative biochemistry of airway lining fluid
220. Chemical nature of in vivo DNA base damage in hydrogen peroxide-treated mammalian cells
221. The role of 8-hydroxyguanine in carcinogenesis
222. Repair of DNA damage induced by reactive oxygen species
223. Endogenous oxidative DNA damage, aging and cancer
224. Oxidative damage to DNA during aging: 8-hydroxy-2′ deoxyguanosine in rat organ DNA and urine
225. Analysis of methylated and oxidized purines in urine by capillary gas chromatography—mass spectrometry
226. Immunoaffinity isolation of urinary 8-hydroxy-2′-deoxyguanosine and 8-hydroxyguanine and quantitation of 8-hydroxy-2′-deoxyguanosine in DNA by polyclonal antibodies
227. Nickel(II)- and Cobalt(II)-dependent damage by hydrogen peroxide to the DNA bases in isolated human chromatin
228. The measurement and mechanism of lipid peroxidation in biological systems
229. Aspects to consider when detecting and measuring lipid peroxidation
230. Lipid peroxidation in human diseases: evidence of red cell oxidative stress after circulatory shock
231. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes
232. Quantitative determination of hydroxy fatty acids as an indicator of in vivo lipid peroxidation; gas chromatography-mass spectrometry methods
233. Quantification of noncycloxygenase derived prostanoids as a marker of oxidative stress
234. 2-like compounds are produced in vivo in humans by a non-cycloxygenase, free radical-catalyzed mechanism
235. Conjugated diene and trans fatty acids in tissue lipids of rats fed an hepatocarcinogenic choline-devoid diet
236. Metal ion-catalyzed oxidation of proteins: biochemical mechanism and biological consequences
237. Acute respiratory distress in adults
238. Identification and partial characterization of angiogenesis bieactivity in the lower respiratory tract after acute lung injury
239. Neutrophils and the adult respiratory distress syndrome
240. Cytokines and sepsis: What are the therapeutic implications?
241. Interleukin-8 (IL-8): the major neutophil chemotactic factor in the lung
242. Phagocytic cell-derived inflammatory mediators and lung disease
243. Occurrence of the adult respiratory distress syndrome in neutropenic patients
244. A critical evaluation of new agents for the treatment of sepsis
245. The presence of neutrophil elastase and evidence of oxidation activity in bronchoalveolar lavage fluid ofpatients with adult respiratory distress syndrome
246. Lung neutrophils in the adult respiratory distress syndrome: Clinical and pathophysiological significance
247. Free radicals and inflammation
248. Superoxide-induced generation of hydroxyl radicals in the presence of iron salts
249. Oxidative damage to hyaluronate and glucose in synovial-fluid during exercise of the inflamed rheumatoid joint
250. Non-caeruloplasmin copper (phenanthroline-copper) is not present in fresh serum or synovial fluid from patients with rheumatoid arthritis
251. Bleomycin-detectable iron in knee-joint synovial fluid from arthritic patients and its relationship to the extracellular antioxidant activities of caeruloplasmin, transferrin and lactoferrin
252. The importance of iron in rheumatoid disease
253. Intraarticular ferritin-bound in rheumatoid arthritis
254. Mechanism of exacerbation of rheumatoid synovitis by total-dose iron-dextran infusion: in vivo demonstration of iron-promoted oxidative stress
255. A pathological role for damaged hyaluronan in synovitis
256. Neutrophils isolated from the synovial fluid of patients with rheumatoid arthritis: priming and activation in vivo
257. Oxygen radical production may be limited by oxygen concentration
258. Effects of antimalarial drugs on interleukin 1-induced cartilage proteoglycan degradation in-vitro
259. Collagenolytic metalloenzymes of the human neutrophil
260. Depolymerization of synovial fluid hyaluronic acid (HA) by the complete myeloperoxidase (MPO) system may involve the formation of an HAMPO ionic complex
261. Inhibition of proteoglycan synthesis by hydrogen peroxide in cultured bovine articular cartilage
262. An experimental model for hydrogen peroxide-induced tissue damage
263. Dynamic studies of the relationship between intraarticular pressure, synovial fluid oxygen tension and lipid peroxidation in the inflamed knee: an example of reperfusion injury
264. Xanthine oxido-reductase is present in human synovium
265. Oxygen-derived free radicals stimulate osteoclastic bone resorption in rodent bone in vitro and in vivo
266. Oxidative damage to lipids within the inflamed human joint provides evidence of radical-mediated hypoxic-reperfusion injury
267. Lipid peroxidation in rheumatoid arthritis: thiobarbituric acid-reactive material and catalytic iron salts in synovial fluid from rheumatoid patients
268. Ascorbate acid transport and accumulation in human neutrophils
269. Breath pentane excretion as marker of disease activity in rheumatoid arthritis
270. Self-perpetuating mechanisms of immunoglobulin G aggregation in rheumatoid inflammation
271. Superoxide dismutase for therapeutic use: clinical experience, dead ends and hopes
272. Long-term outcome of treating rheumatoid arthritis: results after 20 years